Quintiles Transitional Holdings Inc. (NYSE:Q) – Jefferies Group reduced their Q3 2017 earnings estimates for Quintiles Transitional Holdings in a research report issued to clients and investors on Thursday. Jefferies Group analyst D. Windley now expects that the medical research company will earn $1.13 per share for the quarter, down from their previous forecast of $1.20. Jefferies Group has a “Hold” rating and a $94.00 price target on the stock. Jefferies Group also issued estimates for Quintiles Transitional Holdings’ Q4 2017 earnings at $1.34 EPS, FY2017 earnings at $4.56 EPS, Q1 2018 earnings at $1.20 EPS, Q2 2018 earnings at $1.22 EPS, Q3 2018 earnings at $1.27 EPS, Q4 2018 earnings at $1.45 EPS and FY2019 earnings at $5.72 EPS.

A number of other research firms have also weighed in on Q. Zacks Investment Research raised Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 target price for the company in a report on Thursday, July 27th. Citigroup Inc. boosted their price objective on Quintiles Transitional Holdings from $96.00 to $97.00 and gave the stock a “neutral” rating in a report on Monday. William Blair raised Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $70.10 to $93.42 in a report on Friday, August 4th. Stifel Nicolaus reissued a “hold” rating and set a $92.00 price objective on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Finally, Barclays PLC set a $100.00 price objective on Quintiles Transitional Holdings and gave the stock a “buy” rating in a report on Friday, August 4th. Eleven research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $89.94.

TRADEMARK VIOLATION WARNING: “Jefferies Group Research Analysts Reduce Earnings Estimates for Quintiles Transitional Holdings Inc. (Q)” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/08/09/jefferies-group-research-analysts-reduce-earnings-estimates-for-quintiles-transitional-holdings-inc-q.html.

Quintiles Transitional Holdings (Q) opened at 90.67 on Monday. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $92.54. The firm has a market capitalization of $19.95 billion, a P/E ratio of 200.60 and a beta of 0.64. The company has a 50 day moving average of $89.50 and a 200 day moving average of $82.85.

Quintiles Transitional Holdings (NYSE:Q) last issued its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 15.68%. The company had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.96 billion. During the same period in the prior year, the firm earned $0.93 earnings per share. The company’s revenue was up 68.7% on a year-over-year basis.

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in Quintiles Transitional Holdings by 4,217.1% in the first quarter. BlackRock Inc. now owns 7,098,723 shares of the medical research company’s stock valued at $571,660,000 after buying an additional 6,934,290 shares during the period. Gulf International Bank UK Ltd boosted its stake in Quintiles Transitional Holdings by 1.1% in the first quarter. Gulf International Bank UK Ltd now owns 49,056 shares of the medical research company’s stock valued at $3,950,000 after buying an additional 545 shares during the period. WCM Investment Management CA boosted its stake in Quintiles Transitional Holdings by 0.3% in the first quarter. WCM Investment Management CA now owns 558,238 shares of the medical research company’s stock valued at $44,955,000 after buying an additional 1,803 shares during the period. Creative Planning boosted its stake in Quintiles Transitional Holdings by 35.4% in the first quarter. Creative Planning now owns 4,482 shares of the medical research company’s stock valued at $361,000 after buying an additional 1,172 shares during the period. Finally, Candriam Luxembourg S.C.A. boosted its stake in Quintiles Transitional Holdings by 31.5% in the first quarter. Candriam Luxembourg S.C.A. now owns 22,313 shares of the medical research company’s stock valued at $1,797,000 after buying an additional 5,340 shares during the period. 91.83% of the stock is currently owned by hedge funds and other institutional investors.

In other news, major shareholder Cpp Investment Board Private H sold 7,131,165 shares of the stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $84.01, for a total value of $599,089,171.65. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Ari Bousbib sold 92,160 shares of the stock in a transaction on Monday, August 7th. The stock was sold at an average price of $90.35, for a total value of $8,326,656.00. Following the completion of the sale, the insider now directly owns 1,082,919 shares in the company, valued at $97,841,731.65. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,850,560 shares of company stock valued at $744,110,641. 6.40% of the stock is owned by corporate insiders.

Quintiles Transitional Holdings announced that its board has approved a stock repurchase plan on Wednesday, May 24th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the medical research company to purchase up to 5.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Earnings History and Estimates for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.